Sciarretta Sebastiano, Pontremoli Roberto, Rosei Enrico Agabiti, Ambrosioni Ettore, Costa Vittorio, Leonetti Gastone, Pessina Achille Cesare, Trimarco Bruno, Francione Valentina, Tocci Giuliano, Musumeci Maria Beatrice, De Siati Luca, Ferrucci Andrea, Deferrari Giacomo, Volpe Massimo
Second School of Medicine, University of Rome Sapienza, S.Andrea Hospital, Rome, Italy.
J Hypertens. 2009 Feb;27(2):410-7. doi: 10.1097/hjh.0b013e32831bc764.
Renal abnormalities are strongly associated with cardiac damage in essential hypertension. Detection of preclinical cardiac and renal abnormalities is a key clinical step in hypertension management. This study investigated the relationship between ECG abnormalities and microalbuminuria (MAU) in hypertensive patients without overt cardiovascular disease. This relationship, in fact, has never been extensively studied.
The study population was that of Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease, a large observational study including 4121 hypertensive patients in Italy. Patients with overt cardiovascular diseases were excluded from the present analysis. ECGs were centrally read and urinary albumin/creatinine ratio was carefully assessed. Chronic kidney disease was defined by the presence of albuminuria or by a reduction of glomerular filtration rate.
The presence of ECG abnormalities was significantly and directly associated with chronic kidney disease [odds ratio (OR) 1.66, 95% confidence interval (CI) 1.32-2.07, P<0.001], particularly with MAU (OR 1.81, 95% CI 1.39-2.36, P<0.001). Main selected ECG abnormalities were also significantly associated with MAU [rhythm abnormalities (OR 2.94, 95% CI 1.77-4.88, P<0.001), intraventricular conduction defects (OR 1.95, 95% CI 1.32- 2.87, P<0.01), ventricular repolarization alterations (OR 1.84, 95% CI 1.26-2.70, P<0.01) and left-axis deviation (OR 1.87, 95% CI 1.26-2.79, P<0.01)]. After adjustment for confounders, an abnormal ECG and all the main ECG abnormalities remained significantly associated with MAU.
This is the first large and systematic analysis of the relationship between detailed ECG abnormalities and MAU/chronic kidney disease in hypertensive patients without overt cardiovascular diseases. We report a significant and independent relationship between the presence of ECG abnormalities and renal damage in a preclinical stage of hypertension. Identification of ECG abnormalities in hypertension should prompt physicians to careful detection for renal damage, also in order to achieve an accurate risk stratification.
在原发性高血压中,肾脏异常与心脏损害密切相关。检测临床前心脏和肾脏异常是高血压管理中的关键临床步骤。本研究调查了无明显心血管疾病的高血压患者心电图异常与微量白蛋白尿(MAU)之间的关系。事实上,这种关系从未得到广泛研究。
研究人群来自意大利开展高血压患者微量白蛋白尿教育与认知项目,这是一项大型观察性研究,纳入了意大利4121例高血压患者。本分析排除了有明显心血管疾病的患者。心电图由中心统一解读,尿白蛋白/肌酐比值经仔细评估。慢性肾脏病根据蛋白尿的存在或肾小球滤过率降低来定义。
心电图异常的存在与慢性肾脏病显著直接相关[比值比(OR)1.66,95%置信区间(CI)1.32 - 2.07,P<0.001],尤其与MAU相关(OR 1.81,95% CI 1.39 - 2.36,P<0.001)。主要选定的心电图异常也与MAU显著相关[心律失常(OR 2.94,95% CI 1.77 - 4.88,P<0.001)、室内传导阻滞(OR 1.95,95% CI 1.32 - 2.87,P<0.01)、心室复极改变(OR 1.84,95% CI 1.26 - 2.70,P<0.01)和电轴左偏(OR 1.87,95% CI 1.26 - 2.79,P<0.01)]。在对混杂因素进行校正后,异常心电图及所有主要心电图异常仍与MAU显著相关。
这是首次对无明显心血管疾病的高血压患者详细心电图异常与MAU/慢性肾脏病之间的关系进行的大型系统性分析。我们报告了高血压临床前阶段心电图异常的存在与肾脏损害之间存在显著且独立的关系。在高血压患者中识别心电图异常应促使医生仔细检测肾脏损害,以便进行准确的风险分层。